[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |

Global Generic Drug Research and Development Services Supply, Demand and Key Producers, 2023-2029

August 2023 | 127 pages | ID: G5409111EB06EN
GlobalInfoResearch

US$ 4,480.00

E-mail Delivery (PDF)

Download PDF Leaflet

Accepted cards
Wire Transfer
Checkout Later
Need Help? Ask a Question
The global Generic Drug Research and Development Services market size is expected to reach $ million by 2029, rising at a market growth of % CAGR during the forecast period (2023-2029).

Generic Drug Research and Development Services refers to a service that supports pharmaceutical companies in the process of developing generic drugs. It involves a range of activities and expertise aimed at obtaining regulatory approval for a generic version of a brand-name drug. The service typically includes activities such as formulation development, preclinical studies, bioequivalence testing, clinical trial design and execution, regulatory strategy development, and submission preparation. The service provider may also offer project management and regulatory affairs support throughout the development process. The goal of Generic Drug Development Service is to assist pharmaceutical companies in developing generic drugs that are equivalent to the reference product in terms of dosage form, strength, route of administration, quality, safety, and efficacy. This involves demonstrating bioequivalence through rigorous testing and analysis. By utilizing a Generic Drug Development Service, pharmaceutical companies can streamline the drug development process, reduce costs, and ensure compliance with regulatory requirements. These services can be particularly beneficial for smaller pharmaceutical companies or those with limited in-house capabilities in drug development and regulatory affairs.

This report studies the global Generic Drug Research and Development Services demand, key companies, and key regions.

This report is a detailed and comprehensive analysis of the world market for Generic Drug Research and Development Services, and provides market size (US$ million) and Year-over-Year (YoY) growth, considering 2022 as the base year. This report explores demand trends and competition, as well as details the characteristics of Generic Drug Research and Development Services that contribute to its increasing demand across many markets.

Highlights and key features of the study

Global Generic Drug Research and Development Services total market, 2018-2029, (USD Million)

Global Generic Drug Research and Development Services total market by region & country, CAGR, 2018-2029, (USD Million)

U.S. VS China: Generic Drug Research and Development Services total market, key domestic companies and share, (USD Million)

Global Generic Drug Research and Development Services revenue by player and market share 2018-2023, (USD Million)

Global Generic Drug Research and Development Services total market by Type, CAGR, 2018-2029, (USD Million)

Global Generic Drug Research and Development Services total market by Application, CAGR, 2018-2029, (USD Million).

This reports profiles major players in the global Generic Drug Research and Development Services market based on the following parameters – company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include PDG, Navitas Life Sciences, Teva, Avivia, Aavis Pharmaceuticals, CRS, Eurofins, Veeda CRO and JOINN, etc.

This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.

Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World Generic Drug Research and Development Services market.

Detailed Segmentation:

Each section contains quantitative market data including market by value (US$ Millions), by player, by regions, by Type, and by Application. Data is given for the years 2018-2029 by year with 2022 as the base year, 2023 as the estimate year, and 2024-2029 as the forecast year.

Global Generic Drug Research and Development Services Market, By Region:
  • United States
  • China
  • Europe
  • Japan
  • South Korea
  • ASEAN
  • India
  • Rest of World
Global Generic Drug Research and Development Services Market, Segmentation by Type
  • On-line Services
  • Off-line Services
Global Generic Drug Research and Development Services Market, Segmentation by Application
  • Government & Regulatory Agencies
  • Pharmaceutical Company
  • Academic Centre
  • CRO
  • Others
Companies Profiled:
  • PDG
  • Navitas Life Sciences
  • Teva
  • Avivia
  • Aavis Pharmaceuticals
  • CRS
  • Eurofins
  • Veeda CRO
  • JOINN
  • Tigermed
  • PHARMARON
  • DiQi Pharmaceuticals Co, Ltd.
  • AUSUN PHARM
  • Beijing Honghui Meditech Co., Ltd.
  • HiCrystal
  • MEDICILON
  • Duo Rul Pharmaceutlcal Co..Ltd
  • TI Group
  • TIANHENG
  • BIOGINGLAM
  • XINYAO
  • HIPHAR MEDICAL
  • NKD PHARM CO, LTD
  • WuXi AppTec
Key Questions Answered

1. How big is the global Generic Drug Research and Development Services market?

2. What is the demand of the global Generic Drug Research and Development Services market?

3. What is the year over year growth of the global Generic Drug Research and Development Services market?

4. What is the total value of the global Generic Drug Research and Development Services market?

5. Who are the major players in the global Generic Drug Research and Development Services market?

6. What are the growth factors driving the market demand?
1 SUPPLY SUMMARY

1.1 Generic Drug Research and Development Services Introduction
1.2 World Generic Drug Research and Development Services Market Size & Forecast (2018 & 2022 & 2029)
1.3 World Generic Drug Research and Development Services Total Market by Region (by Headquarter Location)
  1.3.1 World Generic Drug Research and Development Services Market Size by Region (2018-2029), (by Headquarter Location)
  1.3.2 United States Generic Drug Research and Development Services Market Size (2018-2029)
  1.3.3 China Generic Drug Research and Development Services Market Size (2018-2029)
  1.3.4 Europe Generic Drug Research and Development Services Market Size (2018-2029)
  1.3.5 Japan Generic Drug Research and Development Services Market Size (2018-2029)
  1.3.6 South Korea Generic Drug Research and Development Services Market Size (2018-2029)
  1.3.7 ASEAN Generic Drug Research and Development Services Market Size (2018-2029)
  1.3.8 India Generic Drug Research and Development Services Market Size (2018-2029)
1.4 Market Drivers, Restraints and Trends
  1.4.1 Generic Drug Research and Development Services Market Drivers
  1.4.2 Factors Affecting Demand
  1.4.3 Generic Drug Research and Development Services Major Market Trends
1.5 Influence of COVID-19 and Russia-Ukraine War
  1.5.1 Influence of COVID-19
  1.5.2 Influence of Russia-Ukraine War

2 DEMAND SUMMARY

2.1 World Generic Drug Research and Development Services Consumption Value (2018-2029)
2.2 World Generic Drug Research and Development Services Consumption Value by Region
  2.2.1 World Generic Drug Research and Development Services Consumption Value by Region (2018-2023)
  2.2.2 World Generic Drug Research and Development Services Consumption Value Forecast by Region (2024-2029)
2.3 United States Generic Drug Research and Development Services Consumption Value (2018-2029)
2.4 China Generic Drug Research and Development Services Consumption Value (2018-2029)
2.5 Europe Generic Drug Research and Development Services Consumption Value (2018-2029)
2.6 Japan Generic Drug Research and Development Services Consumption Value (2018-2029)
2.7 South Korea Generic Drug Research and Development Services Consumption Value (2018-2029)
2.8 ASEAN Generic Drug Research and Development Services Consumption Value (2018-2029)
2.9 India Generic Drug Research and Development Services Consumption Value (2018-2029)

3 WORLD GENERIC DRUG RESEARCH AND DEVELOPMENT SERVICES COMPANIES COMPETITIVE ANALYSIS

3.1 World Generic Drug Research and Development Services Revenue by Player (2018-2023)
3.2 Industry Rank and Concentration Rate (CR)
  3.2.1 Global Generic Drug Research and Development Services Industry Rank of Major Players
  3.2.2 Global Concentration Ratios (CR4) for Generic Drug Research and Development Services in 2022
  3.2.3 Global Concentration Ratios (CR8) for Generic Drug Research and Development Services in 2022
3.3 Generic Drug Research and Development Services Company Evaluation Quadrant
3.4 Generic Drug Research and Development Services Market: Overall Company Footprint Analysis
  3.4.1 Generic Drug Research and Development Services Market: Region Footprint
  3.4.2 Generic Drug Research and Development Services Market: Company Product Type Footprint
  3.4.3 Generic Drug Research and Development Services Market: Company Product Application Footprint
3.5 Competitive Environment
  3.5.1 Historical Structure of the Industry
  3.5.2 Barriers of Market Entry
  3.5.3 Factors of Competition
3.6 Mergers, Acquisitions Activity

4 UNITED STATES VS CHINA VS REST OF THE WORLD (BY HEADQUARTER LOCATION)

4.1 United States VS China: Generic Drug Research and Development Services Revenue Comparison (by Headquarter Location)
  4.1.1 United States VS China: Generic Drug Research and Development Services Market Size Comparison (2018 & 2022 & 2029) (by Headquarter Location)
  4.1.2 United States VS China: Generic Drug Research and Development Services Revenue Market Share Comparison (2018 & 2022 & 2029)
4.2 United States Based Companies VS China Based Companies: Generic Drug Research and Development Services Consumption Value Comparison
  4.2.1 United States VS China: Generic Drug Research and Development Services Consumption Value Comparison (2018 & 2022 & 2029)
  4.2.2 United States VS China: Generic Drug Research and Development Services Consumption Value Market Share Comparison (2018 & 2022 & 2029)
4.3 United States Based Generic Drug Research and Development Services Companies and Market Share, 2018-2023
  4.3.1 United States Based Generic Drug Research and Development Services Companies, Headquarters (States, Country)
  4.3.2 United States Based Companies Generic Drug Research and Development Services Revenue, (2018-2023)
4.4 China Based Companies Generic Drug Research and Development Services Revenue and Market Share, 2018-2023
  4.4.1 China Based Generic Drug Research and Development Services Companies, Company Headquarters (Province, Country)
  4.4.2 China Based Companies Generic Drug Research and Development Services Revenue, (2018-2023)
4.5 Rest of World Based Generic Drug Research and Development Services Companies and Market Share, 2018-2023
  4.5.1 Rest of World Based Generic Drug Research and Development Services Companies, Headquarters (States, Country)
  4.5.2 Rest of World Based Companies Generic Drug Research and Development Services Revenue, (2018-2023)

5 MARKET ANALYSIS BY TYPE

5.1 World Generic Drug Research and Development Services Market Size Overview by Type: 2018 VS 2022 VS 2029
5.2 Segment Introduction by Type
  5.2.1 On-line Services
  5.2.2 Off-line Services
5.3 Market Segment by Type
  5.3.1 World Generic Drug Research and Development Services Market Size by Type (2018-2023)
  5.3.2 World Generic Drug Research and Development Services Market Size by Type (2024-2029)
  5.3.3 World Generic Drug Research and Development Services Market Size Market Share by Type (2018-2029)

6 MARKET ANALYSIS BY APPLICATION

6.1 World Generic Drug Research and Development Services Market Size Overview by Application: 2018 VS 2022 VS 2029
6.2 Segment Introduction by Application
  6.2.1 Government & Regulatory Agencies
  6.2.2 Pharmaceutical Company
  6.2.3 Academic Centre
  6.2.4 CRO
  6.2.5 CRO
6.3 Market Segment by Application
  6.3.1 World Generic Drug Research and Development Services Market Size by Application (2018-2023)
  6.3.2 World Generic Drug Research and Development Services Market Size by Application (2024-2029)
  6.3.3 World Generic Drug Research and Development Services Market Size by Application (2018-2029)

7 COMPANY PROFILES

7.1 PDG
  7.1.1 PDG Details
  7.1.2 PDG Major Business
  7.1.3 PDG Generic Drug Research and Development Services Product and Services
  7.1.4 PDG Generic Drug Research and Development Services Revenue, Gross Margin and Market Share (2018-2023)
  7.1.5 PDG Recent Developments/Updates
  7.1.6 PDG Competitive Strengths & Weaknesses
7.2 Navitas Life Sciences
  7.2.1 Navitas Life Sciences Details
  7.2.2 Navitas Life Sciences Major Business
  7.2.3 Navitas Life Sciences Generic Drug Research and Development Services Product and Services
  7.2.4 Navitas Life Sciences Generic Drug Research and Development Services Revenue, Gross Margin and Market Share (2018-2023)
  7.2.5 Navitas Life Sciences Recent Developments/Updates
  7.2.6 Navitas Life Sciences Competitive Strengths & Weaknesses
7.3 Teva
  7.3.1 Teva Details
  7.3.2 Teva Major Business
  7.3.3 Teva Generic Drug Research and Development Services Product and Services
  7.3.4 Teva Generic Drug Research and Development Services Revenue, Gross Margin and Market Share (2018-2023)
  7.3.5 Teva Recent Developments/Updates
  7.3.6 Teva Competitive Strengths & Weaknesses
7.4 Avivia
  7.4.1 Avivia Details
  7.4.2 Avivia Major Business
  7.4.3 Avivia Generic Drug Research and Development Services Product and Services
  7.4.4 Avivia Generic Drug Research and Development Services Revenue, Gross Margin and Market Share (2018-2023)
  7.4.5 Avivia Recent Developments/Updates
  7.4.6 Avivia Competitive Strengths & Weaknesses
7.5 Aavis Pharmaceuticals
  7.5.1 Aavis Pharmaceuticals Details
  7.5.2 Aavis Pharmaceuticals Major Business
  7.5.3 Aavis Pharmaceuticals Generic Drug Research and Development Services Product and Services
  7.5.4 Aavis Pharmaceuticals Generic Drug Research and Development Services Revenue, Gross Margin and Market Share (2018-2023)
  7.5.5 Aavis Pharmaceuticals Recent Developments/Updates
  7.5.6 Aavis Pharmaceuticals Competitive Strengths & Weaknesses
7.6 CRS
  7.6.1 CRS Details
  7.6.2 CRS Major Business
  7.6.3 CRS Generic Drug Research and Development Services Product and Services
  7.6.4 CRS Generic Drug Research and Development Services Revenue, Gross Margin and Market Share (2018-2023)
  7.6.5 CRS Recent Developments/Updates
  7.6.6 CRS Competitive Strengths & Weaknesses
7.7 Eurofins
  7.7.1 Eurofins Details
  7.7.2 Eurofins Major Business
  7.7.3 Eurofins Generic Drug Research and Development Services Product and Services
  7.7.4 Eurofins Generic Drug Research and Development Services Revenue, Gross Margin and Market Share (2018-2023)
  7.7.5 Eurofins Recent Developments/Updates
  7.7.6 Eurofins Competitive Strengths & Weaknesses
7.8 Veeda CRO
  7.8.1 Veeda CRO Details
  7.8.2 Veeda CRO Major Business
  7.8.3 Veeda CRO Generic Drug Research and Development Services Product and Services
  7.8.4 Veeda CRO Generic Drug Research and Development Services Revenue, Gross Margin and Market Share (2018-2023)
  7.8.5 Veeda CRO Recent Developments/Updates
  7.8.6 Veeda CRO Competitive Strengths & Weaknesses
7.9 JOINN
  7.9.1 JOINN Details
  7.9.2 JOINN Major Business
  7.9.3 JOINN Generic Drug Research and Development Services Product and Services
  7.9.4 JOINN Generic Drug Research and Development Services Revenue, Gross Margin and Market Share (2018-2023)
  7.9.5 JOINN Recent Developments/Updates
  7.9.6 JOINN Competitive Strengths & Weaknesses
7.10 Tigermed
  7.10.1 Tigermed Details
  7.10.2 Tigermed Major Business
  7.10.3 Tigermed Generic Drug Research and Development Services Product and Services
  7.10.4 Tigermed Generic Drug Research and Development Services Revenue, Gross Margin and Market Share (2018-2023)
  7.10.5 Tigermed Recent Developments/Updates
  7.10.6 Tigermed Competitive Strengths & Weaknesses
7.11 PHARMARON
  7.11.1 PHARMARON Details
  7.11.2 PHARMARON Major Business
  7.11.3 PHARMARON Generic Drug Research and Development Services Product and Services
  7.11.4 PHARMARON Generic Drug Research and Development Services Revenue, Gross Margin and Market Share (2018-2023)
  7.11.5 PHARMARON Recent Developments/Updates
  7.11.6 PHARMARON Competitive Strengths & Weaknesses
7.12 DiQi Pharmaceuticals Co, Ltd.
  7.12.1 DiQi Pharmaceuticals Co, Ltd. Details
  7.12.2 DiQi Pharmaceuticals Co, Ltd. Major Business
  7.12.3 DiQi Pharmaceuticals Co, Ltd. Generic Drug Research and Development Services Product and Services
  7.12.4 DiQi Pharmaceuticals Co, Ltd. Generic Drug Research and Development Services Revenue, Gross Margin and Market Share (2018-2023)
  7.12.5 DiQi Pharmaceuticals Co, Ltd. Recent Developments/Updates
  7.12.6 DiQi Pharmaceuticals Co, Ltd. Competitive Strengths & Weaknesses
7.13 AUSUN PHARM
  7.13.1 AUSUN PHARM Details
  7.13.2 AUSUN PHARM Major Business
  7.13.3 AUSUN PHARM Generic Drug Research and Development Services Product and Services
  7.13.4 AUSUN PHARM Generic Drug Research and Development Services Revenue, Gross Margin and Market Share (2018-2023)
  7.13.5 AUSUN PHARM Recent Developments/Updates
  7.13.6 AUSUN PHARM Competitive Strengths & Weaknesses
7.14 Beijing Honghui Meditech Co., Ltd.
  7.14.1 Beijing Honghui Meditech Co., Ltd. Details
  7.14.2 Beijing Honghui Meditech Co., Ltd. Major Business
  7.14.3 Beijing Honghui Meditech Co., Ltd. Generic Drug Research and Development Services Product and Services
  7.14.4 Beijing Honghui Meditech Co., Ltd. Generic Drug Research and Development Services Revenue, Gross Margin and Market Share (2018-2023)
  7.14.5 Beijing Honghui Meditech Co., Ltd. Recent Developments/Updates
  7.14.6 Beijing Honghui Meditech Co., Ltd. Competitive Strengths & Weaknesses
7.15 HiCrystal
  7.15.1 HiCrystal Details
  7.15.2 HiCrystal Major Business
  7.15.3 HiCrystal Generic Drug Research and Development Services Product and Services
  7.15.4 HiCrystal Generic Drug Research and Development Services Revenue, Gross Margin and Market Share (2018-2023)
  7.15.5 HiCrystal Recent Developments/Updates
  7.15.6 HiCrystal Competitive Strengths & Weaknesses
7.16 MEDICILON
  7.16.1 MEDICILON Details
  7.16.2 MEDICILON Major Business
  7.16.3 MEDICILON Generic Drug Research and Development Services Product and Services
  7.16.4 MEDICILON Generic Drug Research and Development Services Revenue, Gross Margin and Market Share (2018-2023)
  7.16.5 MEDICILON Recent Developments/Updates
  7.16.6 MEDICILON Competitive Strengths & Weaknesses
7.17 Duo Rul Pharmaceutlcal Co..Ltd
  7.17.1 Duo Rul Pharmaceutlcal Co..Ltd Details
  7.17.2 Duo Rul Pharmaceutlcal Co..Ltd Major Business
  7.17.3 Duo Rul Pharmaceutlcal Co..Ltd Generic Drug Research and Development Services Product and Services
  7.17.4 Duo Rul Pharmaceutlcal Co..Ltd Generic Drug Research and Development Services Revenue, Gross Margin and Market Share (2018-2023)
  7.17.5 Duo Rul Pharmaceutlcal Co..Ltd Recent Developments/Updates
  7.17.6 Duo Rul Pharmaceutlcal Co..Ltd Competitive Strengths & Weaknesses
7.18 TI Group
  7.18.1 TI Group Details
  7.18.2 TI Group Major Business
  7.18.3 TI Group Generic Drug Research and Development Services Product and Services
  7.18.4 TI Group Generic Drug Research and Development Services Revenue, Gross Margin and Market Share (2018-2023)
  7.18.5 TI Group Recent Developments/Updates
  7.18.6 TI Group Competitive Strengths & Weaknesses
7.19 TIANHENG
  7.19.1 TIANHENG Details
  7.19.2 TIANHENG Major Business
  7.19.3 TIANHENG Generic Drug Research and Development Services Product and Services
  7.19.4 TIANHENG Generic Drug Research and Development Services Revenue, Gross Margin and Market Share (2018-2023)
  7.19.5 TIANHENG Recent Developments/Updates
  7.19.6 TIANHENG Competitive Strengths & Weaknesses
7.20 BIOGINGLAM
  7.20.1 BIOGINGLAM Details
  7.20.2 BIOGINGLAM Major Business
  7.20.3 BIOGINGLAM Generic Drug Research and Development Services Product and Services
  7.20.4 BIOGINGLAM Generic Drug Research and Development Services Revenue, Gross Margin and Market Share (2018-2023)
  7.20.5 BIOGINGLAM Recent Developments/Updates
  7.20.6 BIOGINGLAM Competitive Strengths & Weaknesses
7.21 XINYAO
  7.21.1 XINYAO Details
  7.21.2 XINYAO Major Business
  7.21.3 XINYAO Generic Drug Research and Development Services Product and Services
  7.21.4 XINYAO Generic Drug Research and Development Services Revenue, Gross Margin and Market Share (2018-2023)
  7.21.5 XINYAO Recent Developments/Updates
  7.21.6 XINYAO Competitive Strengths & Weaknesses
7.22 HIPHAR MEDICAL
  7.22.1 HIPHAR MEDICAL Details
  7.22.2 HIPHAR MEDICAL Major Business
  7.22.3 HIPHAR MEDICAL Generic Drug Research and Development Services Product and Services
  7.22.4 HIPHAR MEDICAL Generic Drug Research and Development Services Revenue, Gross Margin and Market Share (2018-2023)
  7.22.5 HIPHAR MEDICAL Recent Developments/Updates
  7.22.6 HIPHAR MEDICAL Competitive Strengths & Weaknesses
7.23 NKD PHARM CO, LTD
  7.23.1 NKD PHARM CO, LTD Details
  7.23.2 NKD PHARM CO, LTD Major Business
  7.23.3 NKD PHARM CO, LTD Generic Drug Research and Development Services Product and Services
  7.23.4 NKD PHARM CO, LTD Generic Drug Research and Development Services Revenue, Gross Margin and Market Share (2018-2023)
  7.23.5 NKD PHARM CO, LTD Recent Developments/Updates
  7.23.6 NKD PHARM CO, LTD Competitive Strengths & Weaknesses
7.24 WuXi AppTec
  7.24.1 WuXi AppTec Details
  7.24.2 WuXi AppTec Major Business
  7.24.3 WuXi AppTec Generic Drug Research and Development Services Product and Services
  7.24.4 WuXi AppTec Generic Drug Research and Development Services Revenue, Gross Margin and Market Share (2018-2023)
  7.24.5 WuXi AppTec Recent Developments/Updates
  7.24.6 WuXi AppTec Competitive Strengths & Weaknesses

8 INDUSTRY CHAIN ANALYSIS

8.1 Generic Drug Research and Development Services Industry Chain
8.2 Generic Drug Research and Development Services Upstream Analysis
8.3 Generic Drug Research and Development Services Midstream Analysis
8.4 Generic Drug Research and Development Services Downstream Analysis

9 RESEARCH FINDINGS AND CONCLUSION


10 APPENDIX

10.1 Methodology
10.2 Research Process and Data Source
10.3 Disclaimer

LIST OF TABLES

Table 1. World Generic Drug Research and Development Services Revenue by Region (2018, 2022 and 2029) & (USD Million), (by Headquarter Location)
Table 2. World Generic Drug Research and Development Services Revenue by Region (2018-2023) & (USD Million), (by Headquarter Location)
Table 3. World Generic Drug Research and Development Services Revenue by Region (2024-2029) & (USD Million), (by Headquarter Location)
Table 4. World Generic Drug Research and Development Services Revenue Market Share by Region (2018-2023), (by Headquarter Location)
Table 5. World Generic Drug Research and Development Services Revenue Market Share by Region (2024-2029), (by Headquarter Location)
Table 6. Major Market Trends
Table 7. World Generic Drug Research and Development Services Consumption Value Growth Rate Forecast by Region (2018 & 2022 & 2029) & (USD Million)
Table 8. World Generic Drug Research and Development Services Consumption Value by Region (2018-2023) & (USD Million)
Table 9. World Generic Drug Research and Development Services Consumption Value Forecast by Region (2024-2029) & (USD Million)
Table 10. World Generic Drug Research and Development Services Revenue by Player (2018-2023) & (USD Million)
Table 11. Revenue Market Share of Key Generic Drug Research and Development Services Players in 2022
Table 12. World Generic Drug Research and Development Services Industry Rank of Major Player, Based on Revenue in 2022
Table 13. Global Generic Drug Research and Development Services Company Evaluation Quadrant
Table 14. Head Office of Key Generic Drug Research and Development Services Player
Table 15. Generic Drug Research and Development Services Market: Company Product Type Footprint
Table 16. Generic Drug Research and Development Services Market: Company Product Application Footprint
Table 17. Generic Drug Research and Development Services Mergers & Acquisitions Activity
Table 18. United States VS China Generic Drug Research and Development Services Market Size Comparison, (2018 & 2022 & 2029) & (USD Million)
Table 19. United States VS China Generic Drug Research and Development Services Consumption Value Comparison, (2018 & 2022 & 2029) & (USD Million)
Table 20. United States Based Generic Drug Research and Development Services Companies, Headquarters (States, Country)
Table 21. United States Based Companies Generic Drug Research and Development Services Revenue, (2018-2023) & (USD Million)
Table 22. United States Based Companies Generic Drug Research and Development Services Revenue Market Share (2018-2023)
Table 23. China Based Generic Drug Research and Development Services Companies, Headquarters (Province, Country)
Table 24. China Based Companies Generic Drug Research and Development Services Revenue, (2018-2023) & (USD Million)
Table 25. China Based Companies Generic Drug Research and Development Services Revenue Market Share (2018-2023)
Table 26. Rest of World Based Generic Drug Research and Development Services Companies, Headquarters (States, Country)
Table 27. Rest of World Based Companies Generic Drug Research and Development Services Revenue, (2018-2023) & (USD Million)
Table 28. Rest of World Based Companies Generic Drug Research and Development Services Revenue Market Share (2018-2023)
Table 29. World Generic Drug Research and Development Services Market Size by Type, (USD Million), 2018 & 2022 & 2029
Table 30. World Generic Drug Research and Development Services Market Size by Type (2018-2023) & (USD Million)
Table 31. World Generic Drug Research and Development Services Market Size by Type (2024-2029) & (USD Million)
Table 32. World Generic Drug Research and Development Services Market Size by Application, (USD Million), 2018 & 2022 & 2029
Table 33. World Generic Drug Research and Development Services Market Size by Application (2018-2023) & (USD Million)
Table 34. World Generic Drug Research and Development Services Market Size by Application (2024-2029) & (USD Million)
Table 35. PDG Basic Information, Area Served and Competitors
Table 36. PDG Major Business
Table 37. PDG Generic Drug Research and Development Services Product and Services
Table 38. PDG Generic Drug Research and Development Services Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 39. PDG Recent Developments/Updates
Table 40. PDG Competitive Strengths & Weaknesses
Table 41. Navitas Life Sciences Basic Information, Area Served and Competitors
Table 42. Navitas Life Sciences Major Business
Table 43. Navitas Life Sciences Generic Drug Research and Development Services Product and Services
Table 44. Navitas Life Sciences Generic Drug Research and Development Services Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 45. Navitas Life Sciences Recent Developments/Updates
Table 46. Navitas Life Sciences Competitive Strengths & Weaknesses
Table 47. Teva Basic Information, Area Served and Competitors
Table 48. Teva Major Business
Table 49. Teva Generic Drug Research and Development Services Product and Services
Table 50. Teva Generic Drug Research and Development Services Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 51. Teva Recent Developments/Updates
Table 52. Teva Competitive Strengths & Weaknesses
Table 53. Avivia Basic Information, Area Served and Competitors
Table 54. Avivia Major Business
Table 55. Avivia Generic Drug Research and Development Services Product and Services
Table 56. Avivia Generic Drug Research and Development Services Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 57. Avivia Recent Developments/Updates
Table 58. Avivia Competitive Strengths & Weaknesses
Table 59. Aavis Pharmaceuticals Basic Information, Area Served and Competitors
Table 60. Aavis Pharmaceuticals Major Business
Table 61. Aavis Pharmaceuticals Generic Drug Research and Development Services Product and Services
Table 62. Aavis Pharmaceuticals Generic Drug Research and Development Services Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 63. Aavis Pharmaceuticals Recent Developments/Updates
Table 64. Aavis Pharmaceuticals Competitive Strengths & Weaknesses
Table 65. CRS Basic Information, Area Served and Competitors
Table 66. CRS Major Business
Table 67. CRS Generic Drug Research and Development Services Product and Services
Table 68. CRS Generic Drug Research and Development Services Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 69. CRS Recent Developments/Updates
Table 70. CRS Competitive Strengths & Weaknesses
Table 71. Eurofins Basic Information, Area Served and Competitors
Table 72. Eurofins Major Business
Table 73. Eurofins Generic Drug Research and Development Services Product and Services
Table 74. Eurofins Generic Drug Research and Development Services Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 75. Eurofins Recent Developments/Updates
Table 76. Eurofins Competitive Strengths & Weaknesses
Table 77. Veeda CRO Basic Information, Area Served and Competitors
Table 78. Veeda CRO Major Business
Table 79. Veeda CRO Generic Drug Research and Development Services Product and Services
Table 80. Veeda CRO Generic Drug Research and Development Services Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 81. Veeda CRO Recent Developments/Updates
Table 82. Veeda CRO Competitive Strengths & Weaknesses
Table 83. JOINN Basic Information, Area Served and Competitors
Table 84. JOINN Major Business
Table 85. JOINN Generic Drug Research and Development Services Product and Services
Table 86. JOINN Generic Drug Research and Development Services Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 87. JOINN Recent Developments/Updates
Table 88. JOINN Competitive Strengths & Weaknesses
Table 89. Tigermed Basic Information, Area Served and Competitors
Table 90. Tigermed Major Business
Table 91. Tigermed Generic Drug Research and Development Services Product and Services
Table 92. Tigermed Generic Drug Research and Development Services Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 93. Tigermed Recent Developments/Updates
Table 94. Tigermed Competitive Strengths & Weaknesses
Table 95. PHARMARON Basic Information, Area Served and Competitors
Table 96. PHARMARON Major Business
Table 97. PHARMARON Generic Drug Research and Development Services Product and Services
Table 98. PHARMARON Generic Drug Research and Development Services Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 99. PHARMARON Recent Developments/Updates
Table 100. PHARMARON Competitive Strengths & Weaknesses
Table 101. DiQi Pharmaceuticals Co, Ltd. Basic Information, Area Served and Competitors
Table 102. DiQi Pharmaceuticals Co, Ltd. Major Business
Table 103. DiQi Pharmaceuticals Co, Ltd. Generic Drug Research and Development Services Product and Services
Table 104. DiQi Pharmaceuticals Co, Ltd. Generic Drug Research and Development Services Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 105. DiQi Pharmaceuticals Co, Ltd. Recent Developments/Updates
Table 106. DiQi Pharmaceuticals Co, Ltd. Competitive Strengths & Weaknesses
Table 107. AUSUN PHARM Basic Information, Area Served and Competitors
Table 108. AUSUN PHARM Major Business
Table 109. AUSUN PHARM Generic Drug Research and Development Services Product and Services
Table 110. AUSUN PHARM Generic Drug Research and Development Services Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 111. AUSUN PHARM Recent Developments/Updates
Table 112. AUSUN PHARM Competitive Strengths & Weaknesses
Table 113. Beijing Honghui Meditech Co., Ltd. Basic Information, Area Served and Competitors
Table 114. Beijing Honghui Meditech Co., Ltd. Major Business
Table 115. Beijing Honghui Meditech Co., Ltd. Generic Drug Research and Development Services Product and Services
Table 116. Beijing Honghui Meditech Co., Ltd. Generic Drug Research and Development Services Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 117. Beijing Honghui Meditech Co., Ltd. Recent Developments/Updates
Table 118. Beijing Honghui Meditech Co., Ltd. Competitive Strengths & Weaknesses
Table 119. HiCrystal Basic Information, Area Served and Competitors
Table 120. HiCrystal Major Business
Table 121. HiCrystal Generic Drug Research and Development Services Product and Services
Table 122. HiCrystal Generic Drug Research and Development Services Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 123. HiCrystal Recent Developments/Updates
Table 124. HiCrystal Competitive Strengths & Weaknesses
Table 125. MEDICILON Basic Information, Area Served and Competitors
Table 126. MEDICILON Major Business
Table 127. MEDICILON Generic Drug Research and Development Services Product and Services
Table 128. MEDICILON Generic Drug Research and Development Services Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 129. MEDICILON Recent Developments/Updates
Table 130. MEDICILON Competitive Strengths & Weaknesses
Table 131. Duo Rul Pharmaceutlcal Co..Ltd Basic Information, Area Served and Competitors
Table 132. Duo Rul Pharmaceutlcal Co..Ltd Major Business
Table 133. Duo Rul Pharmaceutlcal Co..Ltd Generic Drug Research and Development Services Product and Services
Table 134. Duo Rul Pharmaceutlcal Co..Ltd Generic Drug Research and Development Services Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 135. Duo Rul Pharmaceutlcal Co..Ltd Recent Developments/Updates
Table 136. Duo Rul Pharmaceutlcal Co..Ltd Competitive Strengths & Weaknesses
Table 137. TI Group Basic Information, Area Served and Competitors
Table 138. TI Group Major Business
Table 139. TI Group Generic Drug Research and Development Services Product and Services
Table 140. TI Group Generic Drug Research and Development Services Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 141. TI Group Recent Developments/Updates
Table 142. TI Group Competitive Strengths & Weaknesses
Table 143. TIANHENG Basic Information, Area Served and Competitors
Table 144. TIANHENG Major Business
Table 145. TIANHENG Generic Drug Research and Development Services Product and Services
Table 146. TIANHENG Generic Drug Research and Development Services Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 147. TIANHENG Recent Developments/Updates
Table 148. TIANHENG Competitive Strengths & Weaknesses
Table 149. BIOGINGLAM Basic Information, Area Served and Competitors
Table 150. BIOGINGLAM Major Business
Table 151. BIOGINGLAM Generic Drug Research and Development Services Product and Services
Table 152. BIOGINGLAM Generic Drug Research and Development Services Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 153. BIOGINGLAM Recent Developments/Updates
Table 154. BIOGINGLAM Competitive Strengths & Weaknesses
Table 155. XINYAO Basic Information, Area Served and Competitors
Table 156. XINYAO Major Business
Table 157. XINYAO Generic Drug Research and Development Services Product and Services
Table 158. XINYAO Generic Drug Research and Development Services Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 159. XINYAO Recent Developments/Updates
Table 160. XINYAO Competitive Strengths & Weaknesses
Table 161. HIPHAR MEDICAL Basic Information, Area Served and Competitors
Table 162. HIPHAR MEDICAL Major Business
Table 163. HIPHAR MEDICAL Generic Drug Research and Development Services Product and Services
Table 164. HIPHAR MEDICAL Generic Drug Research and Development Services Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 165. HIPHAR MEDICAL Recent Developments/Updates
Table 166. HIPHAR MEDICAL Competitive Strengths & Weaknesses
Table 167. NKD PHARM CO, LTD Basic Information, Area Served and Competitors
Table 168. NKD PHARM CO, LTD Major Business
Table 169. NKD PHARM CO, LTD Generic Drug Research and Development Services Product and Services
Table 170. NKD PHARM CO, LTD Generic Drug Research and Development Services Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 171. NKD PHARM CO, LTD Recent Developments/Updates
Table 172. WuXi AppTec Basic Information, Area Served and Competitors
Table 173. WuXi AppTec Major Business
Table 174. WuXi AppTec Generic Drug Research and Development Services Product and Services
Table 175. WuXi AppTec Generic Drug Research and Development Services Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 176. Global Key Players of Generic Drug Research and Development Services Upstream (Raw Materials)
Table 177. Generic Drug Research and Development Services Typical Customers

LIST OF FIGURES

Figure 1. Generic Drug Research and Development Services Picture
Figure 2. World Generic Drug Research and Development Services Total Market Size: 2018 & 2022 & 2029, (USD Million)
Figure 3. World Generic Drug Research and Development Services Total Market Size (2018-2029) & (USD Million)
Figure 4. World Generic Drug Research and Development Services Revenue Market Share by Region (2018, 2022 and 2029) & (USD Million) , (by Headquarter Location)
Figure 5. World Generic Drug Research and Development Services Revenue Market Share by Region (2018-2029), (by Headquarter Location)
Figure 6. United States Based Company Generic Drug Research and Development Services Revenue (2018-2029) & (USD Million)
Figure 7. China Based Company Generic Drug Research and Development Services Revenue (2018-2029) & (USD Million)
Figure 8. Europe Based Company Generic Drug Research and Development Services Revenue (2018-2029) & (USD Million)
Figure 9. Japan Based Company Generic Drug Research and Development Services Revenue (2018-2029) & (USD Million)
Figure 10. South Korea Based Company Generic Drug Research and Development Services Revenue (2018-2029) & (USD Million)
Figure 11. ASEAN Based Company Generic Drug Research and Development Services Revenue (2018-2029) & (USD Million)
Figure 12. India Based Company Generic Drug Research and Development Services Revenue (2018-2029) & (USD Million)
Figure 13. Generic Drug Research and Development Services Market Drivers
Figure 14. Factors Affecting Demand
Figure 15. World Generic Drug Research and Development Services Consumption Value (2018-2029) & (USD Million)
Figure 16. World Generic Drug Research and Development Services Consumption Value Market Share by Region (2018-2029)
Figure 17. United States Generic Drug Research and Development Services Consumption Value (2018-2029) & (USD Million)
Figure 18. China Generic Drug Research and Development Services Consumption Value (2018-2029) & (USD Million)
Figure 19. Europe Generic Drug Research and Development Services Consumption Value (2018-2029) & (USD Million)
Figure 20. Japan Generic Drug Research and Development Services Consumption Value (2018-2029) & (USD Million)
Figure 21. South Korea Generic Drug Research and Development Services Consumption Value (2018-2029) & (USD Million)
Figure 22. ASEAN Generic Drug Research and Development Services Consumption Value (2018-2029) & (USD Million)
Figure 23. India Generic Drug Research and Development Services Consumption Value (2018-2029) & (USD Million)
Figure 24. Producer Shipments of Generic Drug Research and Development Services by Player Revenue ($MM) and Market Share (%): 2022
Figure 25. Global Four-firm Concentration Ratios (CR4) for Generic Drug Research and Development Services Markets in 2022
Figure 26. Global Four-firm Concentration Ratios (CR8) for Generic Drug Research and Development Services Markets in 2022
Figure 27. United States VS China: Generic Drug Research and Development Services Revenue Market Share Comparison (2018 & 2022 & 2029)
Figure 28. United States VS China: Generic Drug Research and Development Services Consumption Value Market Share Comparison (2018 & 2022 & 2029)
Figure 29. World Generic Drug Research and Development Services Market Size by Type, (USD Million), 2018 & 2022 & 2029
Figure 30. World Generic Drug Research and Development Services Market Size Market Share by Type in 2022
Figure 31. On-line Services
Figure 32. Off-line Services
Figure 33. World Generic Drug Research and Development Services Market Size Market Share by Type (2018-2029)
Figure 34. World Generic Drug Research and Development Services Market Size by Application, (USD Million), 2018 & 2022 & 2029
Figure 35. World Generic Drug Research and Development Services Market Size Market Share by Application in 2022
Figure 36. Government & Regulatory Agencies
Figure 37. Pharmaceutical Company
Figure 38. Academic Centre
Figure 39. CRO
Figure 40. Others
Figure 41. Generic Drug Research and Development Services Industrial Chain
Figure 42. Methodology
Figure 43. Research Process and Data Source


More Publications